Published in PLoS Comput Biol on June 13, 2013
Mutant bacterial sodium channels as models for local anesthetic block of eukaryotic proteins. Channels (Austin) (2016) 0.95
Modulation of a voltage-gated Na+ channel by sevoflurane involves multiple sites and distinct mechanisms. Proc Natl Acad Sci U S A (2014) 0.92
Bacterial voltage-gated sodium channels (BacNa(V)s) from the soil, sea, and salt lakes enlighten molecular mechanisms of electrical signaling and pharmacology in the brain and heart. J Mol Biol (2014) 0.91
Local anesthetic and antiepileptic drug access and binding to a bacterial voltage-gated sodium channel. Proc Natl Acad Sci U S A (2014) 0.89
Molecular dynamics study of binding of µ-conotoxin GIIIA to the voltage-gated sodium channel Na(v)1.4. PLoS One (2014) 0.85
Investigating the size and dynamics of voltage-gated sodium channel fenestrations. Channels (Austin) (2014) 0.82
Locating the route of entry and binding sites of benzocaine and phenytoin in a bacterial voltage gated sodium channel. PLoS Comput Biol (2014) 0.81
Activity-dependent depression of neuronal sodium channels by the general anaesthetic isoflurane. Br J Anaesth (2015) 0.80
Mechanistic Insights into the Modulation of Voltage-Gated Ion Channels by Inhalational Anesthetics. Biophys J (2015) 0.78
Volatile anesthetics inhibit sodium channels without altering bulk lipid bilayer properties. J Gen Physiol (2014) 0.78
Combined computational and experimental analysis of a complex of ribonuclease III and the regulatory macrodomain protein, YmdB. Proteins (2015) 0.77
Fluorine-19 NMR and computational quantification of isoflurane binding to the voltage-gated sodium channel NaChBac. Proc Natl Acad Sci U S A (2016) 0.77
Reduced Nav1.6 Sodium Channel Activity in Mice Increases In Vivo Sensitivity to Volatile Anesthetics. PLoS One (2015) 0.76
Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway. Front Pharmacol (2015) 0.75
Reawakening anaesthesia research. EMBO Rep (2014) 0.75
Hydrocarbon molar water solubility predicts NMDA vs. GABAA receptor modulation. BMC Pharmacol Toxicol (2014) 0.75
Small molecule modulation of voltage gated sodium channels. Curr Opin Struct Biol (2017) 0.75
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science (1998) 39.86
Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem (2004) 17.97
Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science (2005) 17.70
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol (1977) 12.38
The crystal structure of a voltage-gated sodium channel. Nature (2011) 7.82
The voltage sensor in voltage-dependent ion channels. Physiol Rev (2000) 6.86
X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature (2008) 6.02
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature (2008) 5.77
Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science (1994) 5.62
Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta (1977) 5.26
Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel. Nature (2008) 5.09
Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J Pharmacol Exp Ther (1975) 5.07
Development and current status of the CHARMM force field for nucleic acids. Biopolymers (2001) 4.80
A prokaryotic voltage-gated sodium channel. Science (2001) 4.56
Energetics of pore opening in a voltage-gated K(+) channel. Cell (2002) 3.36
Local anesthetics. Effect of pH on use-dependent block of sodium channels in frog muscle. Biophys J (1977) 3.04
Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel. Nature (2012) 2.97
Crystal structure of a voltage-gated sodium channel in two potentially inactivated states. Nature (2012) 2.78
General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci (1999) 2.43
Adaptive biasing force method for scalar and vector free energy calculations. J Chem Phys (2008) 2.08
Structure of a bacterial voltage-gated sodium channel pore reveals mechanisms of opening and closing. Nat Commun (2012) 2.01
Good practices in free-energy calculations. J Phys Chem B (2010) 1.90
A superfamily of voltage-gated sodium channels in bacteria. J Biol Chem (2003) 1.84
Interactions between lipids and voltage sensor paddles detected with tarantula toxins. Nat Struct Mol Biol (2009) 1.56
Clinical and molecular pharmacology of etomidate. Anesthesiology (2011) 1.55
Structural basis for alcohol modulation of a pentameric ligand-gated ion channel. Proc Natl Acad Sci U S A (2011) 1.52
A discrete site for general anesthetics on a postsynaptic receptor. Mol Pharmacol (1995) 1.45
Microsecond simulations indicate that ethanol binds between subunits and could stabilize an open-state model of a glycine receptor. Biophys J (2011) 1.42
Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments. Anesthesiology (1996) 1.38
Identification of binding sites in the nicotinic acetylcholine receptor for TDBzl-etomidate, a photoreactive positive allosteric effector. J Biol Chem (2008) 1.36
Multiple binding sites for the general anesthetic isoflurane identified in the nicotinic acetylcholine receptor transmembrane domain. Proc Natl Acad Sci U S A (2010) 1.33
The pore, not cytoplasmic domains, underlies inactivation in a prokaryotic sodium channel. Biophys J (2005) 1.25
United-atom acyl chains for CHARMM phospholipids. J Phys Chem B (2008) 1.24
Access and binding of local anesthetics in the closed sodium channel. Mol Pharmacol (2008) 1.22
Comparative study of the gating motif and C-type inactivation in prokaryotic voltage-gated sodium channels. J Biol Chem (2009) 1.20
Structure of the pentameric ligand-gated ion channel GLIC bound with anesthetic ketamine. Structure (2012) 1.14
Architecture and pore block of eukaryotic voltage-gated sodium channels in view of NavAb bacterial sodium channel structure. Mol Pharmacol (2012) 1.14
Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals. Mol Pharmacol (2003) 1.13
Anesthetic binding in a pentameric ligand-gated ion channel: GLIC. Biophys J (2010) 1.09
Inhibition of presynaptic sodium channels by halothane. Anesthesiology (1998) 1.07
General anesthetics predicted to block the GLIC pore with micromolar affinity. PLoS Comput Biol (2012) 1.02
Isoflurane inhibits NaChBac, a prokaryotic voltage-gated sodium channel. J Pharmacol Exp Ther (2007) 1.01
Isoflurane alters the structure and dynamics of GLIC. Biophys J (2011) 1.00
Exploring conformational states of the bacterial voltage-gated sodium channel NavAb via molecular dynamics simulations. Proc Natl Acad Sci U S A (2012) 1.00
Local anesthetic inhibition of a bacterial sodium channel. J Gen Physiol (2012) 0.99
Facilitation of recovery from inactivation by external Na+ and location of the activation gate in neuronal Na+ channels. J Neurosci (2000) 0.98
Comparative effects of halogenated inhaled anesthetics on voltage-gated Na+ channel function. Anesthesiology (2009) 0.98
Molecular mechanism for the dual alcohol modulation of Cys-loop receptors. PLoS Comput Biol (2012) 0.95
Isoflurane inhibits the tetrodotoxin-resistant voltage-gated sodium channel Nav1.8. Anesthesiology (2009) 0.95
Sodium channels as targets for volatile anesthetics. Front Pharmacol (2012) 0.94
Interaction between the pore and a fast gate of the cardiac sodium channel. J Gen Physiol (1999) 0.93
The Effects of isoflurane on acetylcholine receptor channels: 3. Effects of conservative polar-to-nonpolar mutations within the channel pore. Mol Pharmacol (2001) 0.92
Hinge-bending motions in the pore domain of a bacterial voltage-gated sodium channel. Biochim Biophys Acta (2012) 0.89
Halothane changes the domain structure of a binary lipid membrane. Langmuir (2012) 0.86
Interaction of anesthetics with open and closed conformations of a potassium channel studied via molecular dynamics and normal mode analysis. Biophys J (2008) 0.85
An atomistic model for simulations of the general anesthetic isoflurane. J Phys Chem B (2010) 0.83
Effects of isoflurane, halothane, and chloroform on the interactions and lateral organization of lipids in the liquid-ordered phase. Langmuir (2011) 0.83
Lipid-dependent effects of halothane on gramicidin channel kinetics: a new role for lipid packing stress. Biochemistry (2009) 0.82
Interaction of diverse voltage sensor homologs with lipid bilayers revealed by self-assembly simulations. Biophys J (2011) 0.81
Perturbed voltage-gated channel activity in perturbed bilayers: implications for ectopic arrhythmias arising from damaged membrane. Prog Biophys Mol Biol (2012) 0.78
Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med (2008) 4.46
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Association between C-reactive protein and age-related macular degeneration. JAMA (2004) 4.16
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA (2007) 3.34
Age-related macular degeneration--a genome scan in extended families. Am J Hum Genet (2003) 2.99
Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology (2013) 2.82
Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet (2003) 2.72
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther (2006) 2.59
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci U S A (2010) 2.43
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Self-assembly and properties of diblock copolymers by coarse-grain molecular dynamics. Nat Mater (2004) 2.07
Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab (2008) 1.97
De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci U S A (2002) 1.95
Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus. Proc Natl Acad Sci U S A (2009) 1.93
Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience. Ultrasound Med Biol (2008) 1.80
Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry (2010) 1.73
An emerging consensus on voltage-dependent gating from computational modeling and molecular dynamics simulations. J Gen Physiol (2012) 1.72
Probing the structure of DNA-carbon nanotube hybrids with molecular dynamics. Nano Lett (2007) 1.65
A novel diagnostic test detects a low frequency of the hemicentin Gln5345Arg variant among Northern Irish age related macular degeneration patients. Mol Vis (2004) 1.64
Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med (2007) 1.63
Understanding nature's design for a nanosyringe. Proc Natl Acad Sci U S A (2004) 1.62
CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered (2006) 1.62
Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol Pharm (2006) 1.61
Embedded cholesterol in the nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (2008) 1.61
Discrimination of methylcytosine from hydroxymethylcytosine in DNA molecules. J Am Chem Soc (2010) 1.59
Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures. Science (2010) 1.59
Computer simulation studies of model biological membranes. Acc Chem Res (2002) 1.56
Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol (2009) 1.53
De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res (2010) 1.52
Intermediate states of the Kv1.2 voltage sensor from atomistic molecular dynamics simulations. Proc Natl Acad Sci U S A (2011) 1.49
Unfolding a linker between helical repeats. J Mol Biol (2005) 1.48
Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med (2011) 1.47
Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet (2013) 1.39
Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. J Am Chem Soc (2011) 1.37
Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr (2006) 1.35
A unitary anesthetic binding site at high resolution. J Biol Chem (2009) 1.34
Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci U S A (2013) 1.34
Multiple binding sites for the general anesthetic isoflurane identified in the nicotinic acetylcholine receptor transmembrane domain. Proc Natl Acad Sci U S A (2010) 1.33
Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. Ophthalmology (2010) 1.32
Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina (2007) 1.31
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol (2013) 1.31
The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered (2007) 1.30
Metadynamics as a tool for exploring free energy landscapes of chemical reactions. Acc Chem Res (2006) 1.30
Identification of a fluorescent general anesthetic, 1-aminoanthracene. Proc Natl Acad Sci U S A (2009) 1.29
Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep (2012) 1.28
Nontoxic membrane-active antimicrobial arylamide oligomers. Angew Chem Int Ed Engl (2004) 1.26
United-atom acyl chains for CHARMM phospholipids. J Phys Chem B (2008) 1.24
Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporos Int (2004) 1.21
Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One (2009) 1.19
Transmembrane peptide-induced lipid sorting and mechanism of Lalpha-to-inverted phase transition using coarse-grain molecular dynamics. Biophys J (2004) 1.19
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
Zwitterionic lipid assemblies: molecular dynamics studies of monolayers, bilayers, and vesicles using a new coarse grain force field. J Phys Chem B (2010) 1.19
Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative. Arch Ophthalmol (2008) 1.19
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17
Evaluation of plasma homocysteine and risk of age-related macular degeneration. Am J Ophthalmol (2006) 1.17
Hydrogen bonding in water. Phys Rev Lett (2003) 1.17
Phosphodiester cleavage in ribonuclease H occurs via an associative two-metal-aided catalytic mechanism. J Am Chem Soc (2008) 1.14
Transmembrane orientation and possible role of the fusogenic peptide from parainfluenza virus 5 (PIV5) in promoting fusion. Proc Natl Acad Sci U S A (2011) 1.14
Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol (2011) 1.13
Conformational changes and gating at the selectivity filter of potassium channels. J Am Chem Soc (2008) 1.13
Towards an understanding of complex biological membranes from atomistic molecular dynamics simulations. Biosci Rep (2002) 1.13
Polarization effects and charge transfer in the KcsA potassium channel. Biophys Chem (2006) 1.12
Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones. Chem Biol (2006) 1.11
C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition (2006) 1.10
A recipe for the computation of the free energy barrier and the lowest free energy path of concerted reactions. J Phys Chem B (2005) 1.09
The role of conformation in ion permeation in a K+ channel. J Am Chem Soc (2008) 1.07
Exploring the gating mechanism in the ClC chloride channel via metadynamics. J Mol Biol (2006) 1.06
Gating pore currents and the resting state of Nav1.4 voltage sensor domains. Proc Natl Acad Sci U S A (2012) 1.06
A 32 kb critical region excluding Y402H in CFH mediates risk for age-related macular degeneration. PLoS One (2011) 1.05
A minimum free energy reaction path for the E2 reaction between fluoro ethane and a fluoride ion. J Am Chem Soc (2004) 1.04
Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab (2010) 1.04
Solute-solvent charge transfer in aqueous solution. Chemphyschem (2005) 1.04
Partitioning of anesthetics into a lipid bilayer and their interaction with membrane-bound peptide bundles. Biophys J (2006) 1.03
The nature of DNA-base-carbon-nanotube interactions. Small (2010) 1.03
Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus. J Med Chem (2013) 1.03
Solution NMR structure of a designed metalloprotein and complementary molecular dynamics refinement. Structure (2008) 1.03
Initial response of the potassium channel voltage sensor to a transmembrane potential. J Am Chem Soc (2009) 1.03
Formamide hydrolysis in alkaline aqueous solution: insight from Ab initio metadynamics calculations. Angew Chem Int Ed Engl (2006) 1.03
Free energy landscape of a DNA-carbon nanotube hybrid using replica exchange molecular dynamics. Nano Lett (2009) 1.03
Probing Membrane Insertion Activity of Antimicrobial Polymers via Coarse-grain Molecular Dynamics. J Chem Theory Comput (2006) 1.02
General anesthetics predicted to block the GLIC pore with micromolar affinity. PLoS Comput Biol (2012) 1.02
Evolutionary imprint of activation: the design principles of VSDs. J Gen Physiol (2014) 1.02
Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One (2007) 1.02
Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr (2007) 1.02
Lipid bilayer perturbations around a transmembrane nanotube: a coarse grain molecular dynamics study. Biophys J (2005) 1.01
Effect of sensor domain mutations on the properties of voltage-gated ion channels: molecular dynamics studies of the potassium channel Kv1.2. Biophys J (2010) 1.00
Exploring conformational states of the bacterial voltage-gated sodium channel NavAb via molecular dynamics simulations. Proc Natl Acad Sci U S A (2012) 1.00
Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol (2003) 0.99
Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci (2013) 0.99
Correspondences between low-energy modes in enzymes: dynamics-based alignment of enzymatic functional families. Protein Sci (2008) 0.99
Conduction in a biological sodium selective channel. J Phys Chem B (2013) 0.99
Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population. Mol Vis (2008) 0.99